Detalhe da pesquisa
1.
Lowering of blood pressure and pulse rate by switching from DPP-4 inhibitor to luseogliflozin in patients with type 2 diabetes complicated with hypertension: A multicenter, prospective, randomized, open-label, parallel-group comparison trial (LUNA study).
Diabetes Res Clin Pract
; 180: 109069, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34563585